The global demand for Congenital Heart Disease Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of 6.7% under the study period 2023 - 2030.
Congenital heart disease (CHD) refers to a group of structural heart abnormalities that are present at birth. These defects can occur during the development of the heart in the womb, leading to structural or functional abnormalities in the heart or the major blood vessels surrounding it. It can involve various parts of the heart, such as the walls, valves, or blood vessels.
The increasing prevalence of CHD, coupled with improved diagnosis and awareness, contributes to market growth. Advancements in medical technology, such as cardiac imaging, surgical techniques, and interventions, have enhanced the diagnosis, treatment, and outcomes of individuals with CHD. There is a growing demand for surgical interventions to repair or correct such complex defects, leading to increased surgical procedures and positively impacting the congenital heart disease (CHD) market. Ongoing research and development efforts in the field of CHD, including genetic studies, regenerative medicine, and tissue engineering, contribute to market growth by developing new treatment modalities and improving patient outcomes. Improved access to healthcare, supportive government initiatives, and growing awareness through campaigns and patient advocacy groups are important drivers of the CHD market.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of congenital heart disease. The growth and trends of congenital heart disease industry provide a holistic approach to this study.
This section of the congenital heart disease market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
By Age Group
By Diagnosis
By Treatment
This section covers the regional outlook, which accentuates current and future demand for the Congenital Heart Disease market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the congenital heart disease market include Abbott Diagnostics, Array BioPharma, AstraZeneca, Becton Dickinson, BG Medicine, Bio-Rad, Boston Scientific, Covance, Critical Diagnostics, Roche, GSK, Janssen Pharmaceuticals, Medtronic, Merck, Mylan. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . CONGENITAL HEART DISEASE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By Age Group
3.7.4 Market Attractiveness Analysis By Diagnosis
3.7.5 Market Attractiveness Analysis By Treatment
3.7.6 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL CONGENITAL HEART DISEASE MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Medications Historic and Forecast Sales by Regions
5.5 Implantable Heart Devices Historic and Forecast Sales by Regions
5.6 Catheter Procedures Historic and Forecast Sales by Regions
5.7 Open-heart Surgery Historic and Forecast Sales by Regions
5.8 Heart Transplant Historic and Forecast Sales by Regions
6 . GLOBAL CONGENITAL HEART DISEASE MARKET ANALYSIS BY APPLICATION